Sonnet BioTherapeutics I... (SONN)
1.54
0.00 (0.00%)
At close: Feb 28, 2025, 3:59 PM
1.50
-2.60%
After-hours: Feb 28, 2025, 04:56 PM EST
Sonnet BioTherapeutics Balance Sheet Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
Cash & Equivalents | 149.46K | 2.27M | 3.05M | 27.62M | 7.35M | 35.65K | 524.11K | 438.49K | 268.57K | 1.53M | n/a | 442.69K | 1.25M | 151.93K | 46.01M | 2.37K | 14.15K | n/a |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 800K | 800K | 800K | 800K | 31.32K | n/a | 55.11K | 56.95K | 318.35K | 352.5M | 83.29K | 108.55K | n/a |
Other Long-Term Assets | 509.15K | 464.19K | 113.28K | -182.27K | 82.96K | 446.64K | 2.86M | 490.33K | 442.74K | 1.73M | n/a | 2.78M | 2.29M | 1.58M | 877.78M | 1.28M | 2.06M | n/a |
Receivables | n/a | 786.57K | n/a | n/a | n/a | n/a | 325.36K | 475.99K | 524.48K | 862.93K | n/a | 393.87K | 384.31K | 180.57K | 4.26M | n/a | n/a | 18.9K |
Inventory | n/a | n/a | -717.3K | n/a | n/a | 478.31K | 335.21K | 460.76K | 539.55K | 726.62K | n/a | 381.41K | 227.02K | 59.27K | n/a | n/a | n/a | n/a |
Other Current Assets | 1.97M | 1.68M | 4M | 2.38M | 575.48K | 4.1K | 490.46K | 424.32K | 461.07K | 1.16M | n/a | 495.17K | 170.77K | 231.91K | 108.48M | 57.81K | 9.4K | n/a |
Total Current Assets | 2.12M | 4.74M | 5.41M | 28.81M | 7.64M | 39.75K | 1.34M | 1.8M | 1.79M | 3.82M | n/a | 1.71M | 2.03M | 623.68K | 158.72M | 60.18K | 23.56K | 18.9K |
Property-Plant & Equipment | 143.94K | 227.06K | 302.81K | 182.27K | 273.81K | 10.47M | 9.76M | 8.55M | 11.51M | 16.64M | n/a | 5.62M | 2.32M | 2.51M | 25.56M | 32.13K | 36.16K | 45.54K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | 16.4M | 25.6M | 31.19M | 31.34M | 19.98M | n/a | 9.92M | 956.32K | 470.16K | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 653.09K | 691.25K | 416.08K | 182.27K | 356.77K | 28.12M | 28.45M | 28.38M | 31.69M | 38.39M | n/a | 18.37M | 5.62M | 4.88M | 1.26B | 1.39M | 2.2M | 45.54K |
Total Assets | 2.77M | 5.43M | 5.83M | 28.99M | 7.99M | 39.75K | 29.79M | 30.18M | 33.49M | 42.21M | n/a | 20.09M | 7.65M | 5.5M | 1.41B | 1.45M | 2.23M | 3.82M |
Account Payables | 2.18M | 2.2M | 4.75M | 3.78M | 2.06M | 1.84M | 2.38M | 3.68M | 3.81M | n/a | n/a | 2.42M | 737.01K | 267.48K | 211.43M | 190.48K | 178.32K | 25.55K |
Deferred Revenue | n/a | 18.63K | 166.43K | 516.37K | 500K | 1.17M | 1.17M | 83.88K | 173.78K | n/a | n/a | n/a | n/a | 14.61K | 1.75M | 20.83K | n/a | 128.56K |
Short-Term Debt | 84.29K | 73.05K | 52.08K | 95.27K | 103.24K | 217.38K | 9.24M | 8.74M | 6.38M | 8.23M | n/a | 759.33K | 264.07K | 2.83M | 250M | 412.5K | 500K | 165.27K |
Other Current Liabilities | 942.49K | 3.23M | 3.19M | 2.31M | 2.06M | 826.77K | 4.03M | 2.4M | 1.67M | 7.95M | n/a | 2.29M | 760.94K | 518.16K | 182.45M | n/a | n/a | n/a |
Total Current Liabilities | 3.21M | 5.52M | 8.16M | 6.7M | 4.72M | 2.89M | 13.03M | 14.73M | 12.11M | 16.18M | n/a | 5.53M | 1.77M | 3.63M | 645.63M | 623.82K | 678.33K | 319.38K |
Long-Term Debt | 46.57K | 130.86K | 203.91K | 30.61K | 250.01K | n/a | 3.67M | 677.39K | 3.97M | 1.11M | n/a | 105.92K | 60.52K | 236.11K | 686.5M | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | -102.3K | 3.58M | 2.16M | 1.96M | 1.8M | n/a | 815.57K | 186.06K | n/a | n/a | 111.84K | 7.8K | 29.89K |
Total Long-Term Liabilities | 46.57K | 130.86K | 203.91K | 30.61K | 250.01K | 7.22M | 8.51M | 3.96M | 7.41M | 4.27M | n/a | 3.32M | 345.03K | 236.11K | 686.5M | 111.84K | 7.8K | 29.89K |
Total Liabilities | 3.26M | 5.66M | 8.37M | 6.73M | 4.97M | 2.89M | 21.54M | 18.69M | 19.52M | 20.45M | n/a | 8.85M | 2.12M | 3.86M | 1.33B | 735.65K | 686.13K | 349.27K |
Total Debt | 130.86K | 203.91K | 255.99K | 125.88K | 353.25K | 217.38K | 10.34M | 9.59M | 10.35M | 9.33M | n/a | 1.35M | 264.07K | 3.03M | 936.5M | 412.5K | 500K | 165.27K |
Common Stock | 65.00 | 175.00 | 554.00 | 6.03K | 1.47K | 555.00 | 373.00 | 305.00 | 2.14K | 2.13K | n/a | 541.00 | 370.00 | 301.00 | 257K | n/a | n/a | 833.00 |
Retained Earnings | -117.68M | -110.24M | -91.41M | -61.69M | -36.71M | -12.44M | -57.12M | -49.11M | -42.21M | -33.01M | n/a | -14.47M | -9.26M | -6.03M | -4.93B | -3.92M | -1.95M | n/a |
Comprehensive Income | n/a | -0.00 | n/a | n/a | n/a | -202.12K | -202.12K | -934.9K | -1.16M | -987.7K | n/a | n/a | n/a | n/a | n/a | n/a | -1.15M | n/a |
Shareholders Equity | -485.74K | -225.98K | -2.54M | 22.26M | 3.02M | -2.85M | 7.43M | 10.71M | 12.82M | 21.76M | n/a | 11.24M | 5.53M | 1.64M | 82.42M | 718.02K | 1.54M | 3.48M |
Total Investments | n/a | n/a | n/a | n/a | n/a | 800K | 800K | 800K | 800K | 31.32K | n/a | 55.11K | 56.95K | 318.35K | 352.5M | 83.29K | 108.55K | 3.74M |